// App-Quantinova.ai

1077 : An analysis of potential elimination strategies for hepatitis C using a budget optimization model for the UK

Researchers

Presenter

  • Olivier Ethgen

Principal Investigators

  • Yuri Sanchez

  • Andy Ingram

  • Mark Nelson

Medical Centers

  • HEOR, AbbVie, Mettawa, IL

  • SERFAN innovation, Namur, Belgium

  • Outcomes Research, Abbvie Ltd, Maidenhead, United Kingdom

  • Chelsea and Westminster Hospital, London, United Kingdom

Locations

  • United States

  • Belgium

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis C

Biomarkers

  • Sustained virological response

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved